Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00207493 · ClinicalTrials.gov registry record · Phase 1
The Participant Agreement for Contact Tracing (PACT) Study: Enhancing Partner Notification Services.
A Phase 1 study, sponsored by Centers for Disease Control and Prevention.
- Completed
- Registry status
- Phase 1
- Development phase
- 494
- Enrollment target
NCT00207493: Completed Phase 1 study, sponsored by Centers for Disease Control and Prevention.
NCT00207493 is a Phase 1 study that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 494 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (723% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00207493, a Phase 1 study, has completed, sponsored by Centers for Disease Control and Prevention.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 494 participants
- Enrollment target
Study Summary
Patients diagnosed with chlamydial infections (a sexually transmitted disease) are asked to notify their sex partners and tell them to seek medical evaluation. This project tests an enhancement to the materials provided to patients to help convince their partners to seek evaluation against the standard of care, which is a brief notification instruction. The desired outcomes are greater levels of notification by participants of their partners and lower levels of reinfection among participants.
Interventions
- BEHAVIORAL Kit enhancement to referral
- PROCEDURE patient referral versus contract referral
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 494 participants |
| Start Date | 2000-10 |
| Est. Completion | 2007-09 |
| Phase | Phase 1 |
What the finished NCT00207493 record still lists
NCT00207493 is an interventional study that assigns participants to a tested intervention. The registered 494 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (723% higher).
The record links to 0 conditions, and to 2 interventions - of which Kit enhancement to referral is the first listed.
NCT00207493 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00207493 about?
NCT00207493 is a clinical study titled "The Participant Agreement for Contact Tracing (PACT) Study: Enhancing Partner Notification Services.". Patients diagnosed with chlamydial infections (a sexually transmitted disease) are asked to notify their sex partners and tell them to seek medical evaluation. This project tests an enhancement to the materials provided to patients to help convince their partners to seek evaluation against the stand...
What is the current status of trial NCT00207493?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 494 participants. The study started on 2000-10. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00207493?
The interventions under investigation include: Kit enhancement to referral (BEHAVIORAL), patient referral versus contract referral (PROCEDURE).
Who is sponsoring clinical trial NCT00207493?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00207493's enrollment target sits among peer trials
494 47th of 2000 higher than 1,954 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03127267 · 495 participants · Phase 3
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
- NCT06400472 · 495 participants · Phase 1
A Study of LY4170156 in Participants With Selected Advanced Solid Tumors
- NCT05283720 · 496 participants · Phase 2
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma
- NCT06417775 · 496 participants · Phase 3
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia